BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26030764)

  • 1. Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and Benin.
    Alferink M; de Zeeuw J; Sopoh G; Agossadou C; Abass KM; Phillips RO; Loth S; Jutten E; Barogui YT; Stewart RE; van der Werf TS; Stienstra Y; Ranchor AV
    PLoS One; 2015; 10(6):e0119926. PubMed ID: 26030764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buruli ulcer treatment: Rate of surgical intervention differs highly between treatment centers in West Africa.
    Wadagni AC; Steinhorst J; Barogui YT; Catraye PM; Gnimavo R; Abass KM; Amofa G; Frimpong M; Sarpong FN; van der Werf TS; Phillips R; Sopoh GE; Johnson CR; Stienstra Y
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007866. PubMed ID: 31658295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paediatric participation scale measuring participation restrictions among former Buruli Ulcer patients under the age of 15 in Ghana and Benin: Development and first validation results.
    Beeres DT; Horstman J; van der Tak P; Phillips RO; Abass KM; van der Werf T; Johnson RC; Sopoh GE; de Zeeuw J; Dijkstra PU; Barogui YT; Stienstra Y
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007273. PubMed ID: 30870426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnopharmacological reports on anti-Buruli ulcer medicinal plants in three West African countries.
    Tsouh Fokou PV; Nyarko AK; Appiah-Opong R; Tchokouaha Yamthe LR; Addo P; Asante IK; Boyom FF
    J Ethnopharmacol; 2015 Aug; 172():297-311. PubMed ID: 26099634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and Treatment of Pain during Treatment of Buruli Ulcer.
    de Zeeuw J; Alferink M; Barogui YT; Sopoh G; Phillips RO; van der Werf TS; Loth S; Molenbuur B; Plantinga M; Ranchor AV; Stienstra Y
    PLoS Negl Trop Dis; 2015; 9(9):e0004076. PubMed ID: 26402069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wound care in Buruli ulcer disease in Ghana and Benin.
    Velding K; Klis SA; Abass KM; Tuah W; Stienstra Y; van der Werf T
    Am J Trop Med Hyg; 2014 Aug; 91(2):313-318. PubMed ID: 24914002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing and managing wounds of Buruli ulcer patients at the primary and secondary health care levels in Ghana.
    Addison NO; Pfau S; Koka E; Aboagye SY; Kpeli G; Pluschke G; Yeboah-Manu D; Junghanss T
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005331. PubMed ID: 28245242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persisting social participation restrictions among former Buruli ulcer patients in Ghana and Benin.
    de Zeeuw J; Omansen TF; Douwstra M; Barogui YT; Agossadou C; Sopoh GE; Phillips RO; Johnson C; Abass KM; Saunderson P; Dijkstra PU; van der Werf TS; Stienstra Y
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3303. PubMed ID: 25392915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
    Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
    Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
    Johnson RC; Sáez-López E; Anagonou ES; Kpoton GG; Ayelo AG; Gnimavo RS; Mignanwande FZ; Houezo JG; Sopoh GE; Addo J; Orford L; Vlasakakis G; Biswas N; Calderon F; Della Pasqua O; Gine-March A; Herrador Z; Mendoza-Losana A; Díez G; Cruz I; Ramón-García S
    Trials; 2022 Jul; 23(1):559. PubMed ID: 35804454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of Pain and Expectations for Its Treatment Among Former Buruli Ulcer Patients.
    Woolley RJ; Velink A; Phillips RO; Thompson WA; Abass KM; van der Werf TS; de Zeeuw J; Stienstra Y
    Am J Trop Med Hyg; 2016 Nov; 95(5):1011-1015. PubMed ID: 27621302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
    Gyamfi E; Narh CA; Quaye C; Abbass A; Dzudzor B; Mosi L
    BMC Microbiol; 2021 Jan; 21(1):4. PubMed ID: 33402095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
    Amoussouhoui AS; Sopoh GE; Wadagni AC; Johnson RC; Aoulou P; Agbo IE; Houezo JG; Boyer M; Nichter M
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006291. PubMed ID: 29529087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients.
    Barogui YT; Klis S; Bankolé HS; Sopoh GE; Mamo S; Baba-Moussa L; Manson WL; Johnson RC; van der Werf TS; Stienstra Y
    PLoS Negl Trop Dis; 2013; 7(1):e2010. PubMed ID: 23359827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
    Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
    Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the participation scale among former buruli ulcer patients in Ghana and Benin.
    de Zeeuw J; Douwstra M; Omansen TF; Sopoh GE; Johnson C; Phillips RO; Alferink M; Saunderson P; Van der Werf TS; Dijkstra PU; Stienstra Y
    PLoS Negl Trop Dis; 2014; 8(11):e3254. PubMed ID: 25393289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.
    Velink A; Woolley RJ; Phillips RO; Abass KM; van der Werf TS; Agumah E; de Zeeuw J; Klis S; Stienstra Y
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005261. PubMed ID: 28033343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana.
    Amoako YA; Loglo AD; Frimpong M; Agbavor B; Abass MK; Amofa G; Ofori E; Ampadu E; Asiedu K; Stienstra Y; Wansbrough-Jones M; van der Werf T; Phillips RO
    BMC Infect Dis; 2021 Apr; 21(1):331. PubMed ID: 33832460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
    Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
    Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital.
    Please HR; Vas Nunes JH; Patel R; Pluschke G; Tholley M; Ruf MT; Bolton W; Scott JA; Grobusch MP; Bolkan HA; Brown JM; Jayne DG
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009862. PubMed ID: 34644298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.